Will Lactobacillus Increase Cure Rate After Treatment of Bacterial Vaginosis and Chronic Vulvovaginal Candida
NCT02295579 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2019-08-14
Summary
From the earlier studies the investigators have treated women with bacterial vaginosis and cronic vulvovaginal candida. The investigators have then treated them with laktobacilli 10 days for 2 month. The investigators will continue to follow them and investigate if treatment with lactobacilli every week for 6 month will increase cure rate.
Conditions
- Bacterial Vaginosis
Interventions
- OTHER
-
lactobacillus (EcoVag)
Probiotic human lactobacillus (L. gasseri and L rahmnosus)
Sponsors & Collaborators
-
Skaraborg Hospital
lead OTHER_GOV
Principal Investigators
-
Per-Göran Larsson · Department of Ob/Gyn Skaraborgs hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2015-06-30
- Completion
- 2015-11-30
Countries
- Sweden
Study Locations
More Related Trials
-
Prevention of Persistence of Bacterial Vaginosis
NCT00741845 ·Status: TERMINATED ·Phase: PHASE3
-
Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network
NCT00503542 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis
NCT01055106 ·Status: COMPLETED ·Phase: PHASE2
-
Suppressive Antibacterial Therapy With Once-Weekly Secnidazole Granules to Prevent Recurrent Bacterial Vaginosis; A Pilot Study
NCT05033743 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Vaginal Infection Study 2
NCT00694928 ·Status: COMPLETED ·Phase: PHASE3
-
Title of the Protocol: Combined Use of Vaginal Clindamycin Cream and Oral Metronidazole Versus Oral Metronidazole
NCT07247851 ·Status: COMPLETED ·Phase: NA
-
Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age
NCT06458543 ·Status: RECRUITING ·Phase: PHASE4
-
Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis
NCT03234517 ·Status: UNKNOWN ·Phase: PHASE2
-
Vaginal Infection Study
NCT00616330 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Composition and Bacterial Diversity of the Vaginal Microbiota in Healthy Versus Pathological Conditions (Bacterial Vaginosis) Using a Targeted Metagenomic Approach (RNA 16s)
NCT04989543 ·Status: COMPLETED ·Phase: NA
-
A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women
NCT02210689 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Bacterial Vaginosis (BV) With Tinidazole
NCT00334633 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity
NCT03954990 ·Status: TERMINATED ·Phase: PHASE1
-
Probiotic Versus Placebo as Adjuvant for Bacterial Vaginosis Treatment During Pregnancy
NCT01558388 ·Status: UNKNOWN ·Phase: PHASE4
-
Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis
NCT00642980 ·Status: COMPLETED ·Phase: PHASE4
-
Examining the Impact of Tampon Use on the Vaginal Microbiota
NCT03346759 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Blue Light Emitting Diode in the Treatment of Women With Bacterial Vaginosis: a Clinical Trial
NCT03500107 ·Status: RECRUITING ·Phase: NA
-
Screen-and-treat Strategy for Vaginal Flora Abnormalities in Pregnant Women at High Risk of Preterm Birth
NCT06349122 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Open Study of the Efficacy of the Local Treatment With Polygynax of Bacterial and/or Mycotic Vaginitis
NCT02444481 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Metronidazole, Nystatin and Dexamethasone Combination Therapy in Bacterial and Fungal Vaginal Infections
NCT02186145 ·Status: UNKNOWN ·Phase: PHASE3
-
Pharmacokinetic Study of DARE-BV1
NCT05354050 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-Human Safety and Pharmacokinetic Trial of GenSci142 Administered as Single Ascending Doses in Healthy Chinese Women
NCT07302035 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Collection of Vaginal Microbiota Samples (VAGINOTYPE)
NCT06486519 ·Status: COMPLETED
-
Human Microbiome and Healthcare Associated Infections - Nursing Home Dwelling Older Veterans
NCT04218799 ·Status: COMPLETED ·Phase: PHASE4
-
A User Study With Vernivia® for Bacterial Vaginosis.
NCT06104098 ·Status: COMPLETED ·Phase: NA